萊斯康製藥 LXRX 深 滬
交易中 10-07 10:20:45 美东时间
1.745
-0.005
-0.29%
華盛通- 最 高1.75
- 今 開1.73
- 成交量 10.68万股
- 最 低 1.7137
- 昨 收 1.75
- 總市值 7.76亿
- 52周最高 2.68
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 1.10
- 委 比 -26.09%
- 總股本 4.45亿
- 歷史最高 19.62
- 量 比 0.56
- 振 幅 2.07%
- 歷史最低 0.2836
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lexicon Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript
Lexicon Pharmaceuticals (NASDAQ:LXRX) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consul...
10-06 15:51
美股大行评级 | 潜在涨幅919.61%！HC Wainwright上调NeuroSense Therapeutics目标价至52美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持NeuroSense Therapeutics"买入"评级，目标价从8美元升至52美元；HC Wainwright & Co.：维持艾切托"买入"评级，目标价从27美元升至34美元
09-29 08:33
Cantor Fitzgerald Initiates Coverage On Lexicon Pharmaceuticals with Overweight Rating, Announces Price Target of $8
Cantor Fitzgerald analyst Steve Seedhouse initiates coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Overweight rating and announces Price Target of $8.
09-28 18:39
Beta Bionics, J.B. Hunt Transport And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 100 points on Wednesday. Shares of Beta Bionics Inc (NASDAQ:BBNX) fell sharply in pre-market trading after the company reported the pricing of public offering of common stock and pre-funded warrants. Beta Bionics...
09-16 20:01
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Shares of Tempest Therapeutics Inc (NASDAQ:TPST) rose sharply in pre-market trading after the California-based clinical-stage biotechnology company announced an exclusive option agreement with Hebei Senlang Biotechnology Co., Ltd. According to the announcement, the agreement gives Tempest an exclusi...
09-16 17:04
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
Lexicon Pharmaceuticals, Inc. announced that its management will present at three upcoming investor conferences in New York on September 9, 10, and 14, 2026. The events include the Citi 2026 Biopharma Back to School Conference, the 2026 Cantor Global Healthcare Conference, and the H.C. Wainwright 28th Annual Global Investment Conference. Live events and replays can be accessed via the company’s website. Lexicon is a biopharmaceutical company focu...
09-01 20:05
Lexicon earns third $10M Novo milestone
Lexicon Pharmaceuticals (LXRX) said it earned a third $10M milestone payment from Novo Nordisk after reaching a patient-dosing milestone in the Phase 1 trial of obesity drug candidate LX9851. The paym...
08-24 20:42
Lexicon 2026年第二季度财报：许可收入未重现，营收降至69.2万美元
Lexicon（LXRX）2026年第二季度营收69.2万美元，稀释每股亏损0.07美元，期末现金及投资1.906亿美元；上年许可收入未再出现，公司由盈转亏。
08-07 01:49
Lexicon Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 financial results.
Lexicon Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 financial results.
08-06 20:46
Lexicon Pharmaceuticals Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $692.000K Miss $3.998M Estimate
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 800 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $692.000 ...
08-06 19:48
